- Home
- CIGI vs BPMC Comparison
CIGI vs BPMC Comparison
Compare CIGI & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIGI
- BPMC
- Stock Information
- Founded
- CIGI 1972
- BPMC 2008
- Country
- CIGI Canada
- BPMC United States
- Employees
- CIGI N/A
- BPMC N/A
- Industry
- CIGI
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- CIGI
- BPMC Health Care
- Exchange
- CIGI Nasdaq
- BPMC Nasdaq
- Market Cap
- CIGI 6.0B
- BPMC 5.8B
- IPO Year
- CIGI N/A
- BPMC 2015
- Fundamental
- Price
- CIGI $120.48
- BPMC $101.35
- Analyst Decision
- CIGI Buy
- BPMC Buy
- Analyst Count
- CIGI 7
- BPMC 18
- Target Price
- CIGI $157.43
- BPMC $125.88
- AVG Volume (30 Days)
- CIGI 149.0K
- BPMC 789.4K
- Earning Date
- CIGI 05-06-2025
- BPMC 05-01-2025
- Dividend Yield
- CIGI 0.25%
- BPMC N/A
- EPS Growth
- CIGI 38.82
- BPMC N/A
- EPS
- CIGI 2.86
- BPMC N/A
- Revenue
- CIGI $4,961,214,000.00
- BPMC $562,121,000.00
- Revenue This Year
- CIGI $13.69
- BPMC $44.49
- Revenue Next Year
- CIGI $6.68
- BPMC $33.04
- P/E Ratio
- CIGI $42.07
- BPMC N/A
- Revenue Growth
- CIGI 13.50
- BPMC 99.19
- 52 Week Low
- CIGI $100.86
- BPMC $73.04
- 52 Week High
- CIGI $156.96
- BPMC $121.90
- Technical
- Relative Strength Index (RSI)
- CIGI 48.35
- BPMC 56.34
- Support Level
- CIGI $116.50
- BPMC $94.38
- Resistance Level
- CIGI $122.29
- BPMC $102.52
- Average True Range (ATR)
- CIGI 2.65
- BPMC 3.77
- MACD
- CIGI -0.64
- BPMC -0.38
- Stochastic Oscillator
- CIGI 28.74
- BPMC 79.29
About CIGI Colliers International Group Inc. Subordinate Voting Shares
Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are; Real Estate Services, Engineering, Investment Management, and Corporate. Maximum revenue for the company is generated from its Real Estate Services segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, property sales brokerage, and lease brokerage services, among others. Geographically, the company generates maximum revenue from the United States and the rest from Canada, Australia, the United Kingdom, Poland, China, India, and other regions.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.